a maker of biologic therapeutics for oncology and inflammatory diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with XENE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then XENE could also see price increases.
Ticker / NAME | Correlation To CHRS | 1D Price Change % | ||
---|---|---|---|---|
CHRS | 100% | +0.59% | ||
XENE - CHRS | 40% Loosely correlated | -0.07% | ||
QSI - CHRS | 37% Loosely correlated | -8.67% | ||
BPMC - CHRS | 36% Loosely correlated | +1.14% | ||
RCUS - CHRS | 35% Loosely correlated | -2.60% | ||
PRME - CHRS | 34% Loosely correlated | -3.00% | ||
More |